Current market catalysts

Intuitive Surgical Published Systematic Review And Meta-Analysis In Peer-Reviewed Annals Of Surgery Open.

Bridgebio Announces New KRASG12C Data And Strategic Prioritization Of BBO-8520 In Combination With Checkpoint Inhibitor In 2L+ KRASG12C Inhibitor-Experienced NSCLC Patients And BBO-11818 And BBO-10203 In KRAS-Mutant Cancers

Bitcoin, Ethereum, Dogecoin Flat as XRP Jumps 2%: Traders Call BTC Pullback 'Normal'

Bitcoin holds near $78,000 as markets await U.S. inflation data and Fed decision. Traders added that Bitcoin pullbacks around golden crosses are normal.

8-K filing — Xponential Fitness, Inc. (XPOF)

Filed: 2026-09-08 AccNo: 0001193125-26-385205 Size: 202 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

8-K filing — Loop Industries, Inc. (LOOP)

Filed: 2026-09-08 AccNo: 0001437749-26-029827 Size: 184 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

8-K filing — InnovAge Holding Corp. (INNV)

Filed: 2026-09-08 AccNo: 0001834376-26-000047 Size: 571 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

8-K filing — Barnes & Noble Education, Inc. (BNED)

Filed: 2026-09-08 AccNo: 0001634117-26-000090 Size: 448 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

8-K filing — Northwest Bancshares, Inc. (NWBI)

Filed: 2026-09-08 AccNo: 0001471265-26-000040 Size: 6 MB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

8-K filing — Sphere 3D Corp. (ANY)

Filed: 2026-09-08 AccNo: 0001213900-26-098043 Size: 243 KB Item 1.01: Entry into a Material Definitive Agreement

8-K filing — NEKTAR THERAPEUTICS (NKTR)

Filed: 2026-09-08 AccNo: 0001213900-26-098042 Size: 187 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

8-K filing — Snap Inc (SNAP)

Filed: 2026-09-08 AccNo: 0001193125-26-385199 Size: 132 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Chime Inks Deal To Acquire Stride Bank For $950M

ServiceTitan Q2 Adj. EPS $0.40 Beats $0.35 Estimate, Sales $292.756M Beat $285.957M Estimate

Braze Q2 Adj. EPS $0.19 Beats $0.16 Estimate, Sales $227.230M Beat $219.918M Estimate

InnovAge Holding Q4 EPS $0.06 Misses $0.07 Estimate, Sales $261.951M Beat $238.267M Estimate

Broadcom CEO Says Capital Allocation Likely To Focus On Increased Dividends, Stock Buybacks

InnovAge Holding Sees FY2027 Sales $1.050B-$1.085B vs $1.038B Est

ServiceTitan Raises FY2027 Sales Guidance from $1.130B-$1.140B to $1.139B-$1.144B vs $1.138B Est

Braze Sees Q3 Adj EPS $0.13-$0.14 vs $0.16 Est; Sees Sales $229.000M-$230.000M vs $227.861M Est

Suniva Announces Completion Of $835M Debt And Equity Raise To Fund 4.5 GW South Carolina Solar Cell Plant; Expects Completion Late 2027

ServiceTitan Sees Q3 Sales $285.000M-$287.000M vs $287.874M Est

LiqTech International Announces David Noerby Foss Kowalczyk To Resign As CFO And COO Effective November 30, 2026

Braze Raises FY2027 Adj EPS Guidance from $0.61-$0.65 to $0.64-$0.65 vs $0.63 Est; Raises FY2027 Sales Guidance from $884.000M-$889.000M to $910.000M-$913.000M vs $898.085M Est

Protagonist Therapeutics Announces $300M Buyback Plan

Carlsmed Announces Promotion Of Jeff Bertolini To COO, Effective Immediately

Mission Produce Q3 Adj. EPS $0.18 Beats $0.12 Estimate, Sales $450.000M Beat $367.475M Estimate

8-K filing — Everus Construction Group, Inc. (ECG)

Filed: 2026-09-08 AccNo: 0002015845-26-000056 Size: 169 KB Item 1.01: Entry into a Material Definitive Agreement Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

8-K filing — Braze, Inc. (BRZE)

Filed: 2026-09-08 AccNo: 0001676238-26-000039 Size: 705 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

8-K filing — Braveheart Bio, Inc. (BRVE)

Filed: 2026-09-08 AccNo: 0001628280-26-060904 Size: 367 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

8-K filing — Wheeler Real Estate Investment Trust, Inc. (WHLRL)

Filed: 2026-09-08 AccNo: 0001527541-26-000331 Size: 196 KB Item 3.02: Unregistered Sales of Equity Securities